Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric M Horwitz

Showing results (41-50 of 192) with videos related to

Pageof 20
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Long-term androgen deprivation increases Grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapySteven J Feigenberg, Alexandra L Hanlon, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|July 23, 2003
The Gleason score shift: score four and seven years agoDerek B Chism, Alexandra L Hanlon, Patricia Troncoso, et al.
American Journal of Clinical Oncology|October 7, 2006
A prostate specific antigen (PSA) bounce greater than 1.4 ng/mL Is clinically significant after external beam radiotherapy for prostate cancerSteven J Feigenberg, Alexandra L Hanlon, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|July 29, 2010
Intensity Modulated Radiation Therapy Reduces Gastrointestinal Toxicity in Patients Treated with Androgen Deprivation Therapy for Prostate CancerNavesh K Sharma, Tianyu Li, David Y Chen, et al.
Carcinogenesis|April 12, 2006
Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progressionRobert G Uzzo, Paul L Crispen, Konstantin Golovine, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2010
Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancerNavesh K Sharma, Tianyu Li, David Y Chen, et al.
Urology|August 2, 2003
Positive prostate biopsy laterality and implications for stagingMark K Buyyounouski, Eric M Horwitz, Alexandra L Hanlon, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
Radiation dose and late failures in prostate cancerPeter B Morgan, Alexandra L Hanlon, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|March 9, 2005
What pretreatment prostate-specific antigen level warrants long-term androgen deprivation?Steven J Feigenberg, Alexandra L Hanlon, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatmentMark K Buyyounouski, Eric M Horwitz, Robert A Price, et al.
Pageof 20

Showing results (41-50 of 192) with videos related to

Sort By:
Pageof 20
International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Long-term androgen deprivation increases Grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapySteven J Feigenberg, Alexandra L Hanlon, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|July 23, 2003
The Gleason score shift: score four and seven years agoDerek B Chism, Alexandra L Hanlon, Patricia Troncoso, et al.
American Journal of Clinical Oncology|October 7, 2006
A prostate specific antigen (PSA) bounce greater than 1.4 ng/mL Is clinically significant after external beam radiotherapy for prostate cancerSteven J Feigenberg, Alexandra L Hanlon, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|July 29, 2010
Intensity Modulated Radiation Therapy Reduces Gastrointestinal Toxicity in Patients Treated with Androgen Deprivation Therapy for Prostate CancerNavesh K Sharma, Tianyu Li, David Y Chen, et al.
Carcinogenesis|April 12, 2006
Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progressionRobert G Uzzo, Paul L Crispen, Konstantin Golovine, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2010
Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancerNavesh K Sharma, Tianyu Li, David Y Chen, et al.
Urology|August 2, 2003
Positive prostate biopsy laterality and implications for stagingMark K Buyyounouski, Eric M Horwitz, Alexandra L Hanlon, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
Radiation dose and late failures in prostate cancerPeter B Morgan, Alexandra L Hanlon, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|March 9, 2005
What pretreatment prostate-specific antigen level warrants long-term androgen deprivation?Steven J Feigenberg, Alexandra L Hanlon, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatmentMark K Buyyounouski, Eric M Horwitz, Robert A Price, et al.
Pageof 20